BriaCell Therapeutics Corp. (OTCMKTS:BCTXF – Get Free Report) shares rose 0.7% on Monday . The stock traded as high as $2.96 and last traded at $2.94. Approximately 116,217 shares changed hands during mid-day trading, an increase of 6,152% from the average daily volume of 1,859 shares. The stock had previously closed at $2.92.
BriaCell Therapeutics Trading Up 0.7%
The firm has a market capitalization of $2.27 million, a PE ratio of -0.01 and a beta of 1.09. The firm has a 50-day moving average of $3.97 and a two-hundred day moving average of $2.57.
About BriaCell Therapeutics
BriaCell Therapeutics Corp. operates as a clinical-stage biotechnology company that specializes in immunotherapy for advanced breast cancer. It is advancing its targeted immunotherapy program by conducting a Phase I/IIA clinical trial with Bria-IMT in combination with an immune checkpoint inhibitor and a companion diagnostic test, BriaDx, to identify patients to benefit from Bria-IMT.
Featured Stories
- Five stocks we like better than BriaCell Therapeutics
- What Are the U.K. Market Holidays? How to Invest and Trade
- UnitedHealth Insiders Double Down: Is UNH Stock a Value Play?
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- What Ray Dalio’s Latest Moves Tell Investors
- Investing in Construction Stocks
- Amazon: Why May Is the Last Month to Get the Stock at a Discount
Receive News & Ratings for BriaCell Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BriaCell Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
